Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

JAMA network open - United States
doi 10.1001/jamanetworkopen.2020.0107
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Satisfaction With Oral Anticoagulants in Patients With Atrial Fibrillation

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2018English

Prevention of Cardiovascular Outcomes in Diabetic Patients With Atrial Fibrillation: Direct Oral Anticoagulants or Warfarin?

Clinical pharmacology and therapy
2019English

Characteristics and Outcomes in Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulants in Off-Label Doses

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2020English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

How Prepared Are Pharmacists to Support Atrial Fibrillation Patients in Adhering to Newly Prescribed Oral Anticoagulants?

International Journal of Clinical Pharmacy
ToxicologyPharmacyPharmacologyPharmaceutical Science
2017English

Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment

Pharmacy
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy